Nanogen to Consolidate POC Manufacturing Operations in San Diego, Transfer Listing to Nasdaq Capital Market | GenomeWeb
This article has been updated from a previous version to include information about the company's listing transfer.
 
NEW YORK (GenomeWeb News) – In a move to reduce costs, Nanogen said Thursday that it plans to transfer its Toronto, Canada, point-of-care manufacturing operations to its San Diego facility and to cease all manufacturing operations in Canada by the end of the year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.